When a couple has more than one embryo ready for transfer, a natural question follows: why not transfer two and improve the chances of pregnancy? It seems like simple logic—two embryos should mean two opportunities to conceive.
While understandable, the reality is more complex. Transferring two embryos only increases the chance of pregnancy slightly in a single IVF cycle, but it dramatically increases the likelihood of twins. Twin pregnancies are not simply "two babies at once." They represent the single biggest avoidable complication associated with IVF, carrying significantly greater risks for both the mother and the babies.
For most couples, transferring one embryo at a time while freezing the remaining embryos provides a similar overall chance of taking home a healthy baby, but with far fewer risks. Here's why.
The terms are straightforward.
The most important concept is Elective Single Embryo Transfer (eSET). This means a couple has two or more good-quality embryos available but intentionally chooses to transfer only one while freezing the others for future use.
The decision isn't forced by having only one embryo. It's a planned strategy designed to maximise safety without significantly reducing the chance of success.
Many people naturally assume that transferring two embryos should double their chances of pregnancy. Unfortunately, biology doesn't work that way.
Each embryo implants independently. Having two embryos in the uterus does increase the probability that at least one will implant, but the improvement is relatively modest.
Studies have shown that transferring two good-quality blastocysts increases the live birth rate only slightly compared with transferring one. However, what increases dramatically is the likelihood that both embryos implant, resulting in twins.
Another important consideration is that when two embryos are transferred but only one continues developing, the remaining pregnancy may still carry a higher risk of miscarriage and pregnancy complications than if only one embryo had been transferred in the first place.
Twins are often viewed as a welcome bonus by patients, but from a medical perspective, a twin pregnancy is considered high risk.
With double embryo transfer, twin pregnancy rates exceed 30%. In comparison, single embryo transfer results in twins only around 1–2% of the time, similar to natural conception.
Twin pregnancies significantly increase the risk of:
For mothers, twin pregnancies also increase the likelihood of:
Large national studies consistently show that babies born after single embryo transfer are generally heavier at birth, less likely to be premature, and have lower rates of newborn complications than babies from double embryo transfer.
These safety benefits are one of the main reasons fertility specialists now recommend transferring a single embryo whenever appropriate.
The most meaningful comparison isn't one embryo transfer versus another. It's the overall chance of having a baby from one complete IVF egg collection.
Modern IVF allows embryos to be cultured to the blastocyst stage before selecting the strongest embryo for transfer. Remaining healthy embryos are safely frozen for future Frozen Embryo Transfer (FET) cycles.
If the first transfer is unsuccessful, another frozen embryo can be transferred later, with frozen embryo transfers now achieving success rates similar to fresh transfers.
When all transfers from one egg retrieval cycle are considered together, elective single embryo transfer provides a cumulative live birth rate comparable to, and in some studies even higher than, double embryo transfer—while avoiding most twin pregnancies.
Importantly, choosing one embryo doesn't waste the others. Every suitable embryo still has an opportunity to be transferred—just one at a time.
Preimplantation Genetic Testing for Aneuploidy (PGT-A) further strengthens the case for transferring a single embryo.
PGT-A identifies embryos with the correct number of chromosomes, helping fertility specialists select those with the highest likelihood of implantation and healthy pregnancy.
A single chromosomally normal (euploid) blastocyst already has an excellent chance of resulting in a live birth.
Research has shown that even after a failed transfer of one euploid embryo, transferring two screened embryos during the next cycle does not significantly improve live birth rates. Instead, it simply increases the likelihood of twin pregnancy.
When embryo quality has already been optimised through genetic screening, adding a second embryo usually offers little additional benefit.
Although single embryo transfer is recommended for most patients, there are situations where transferring two embryos may still be discussed.
Even in these situations, the potential benefits must be carefully balanced against the increased risks associated with twin pregnancy.
Research also suggests that for women aged 35 years and older, transferring two blastocysts often provides little or no meaningful improvement in live birth rates while still increasing the chance of twins.
Interestingly, some studies indicate that transferring one excellent-quality embryo may produce better outcomes than transferring one excellent embryo together with a poorer-quality embryo.
For this reason, the decision should always be individualised based on age, embryo quality, previous IVF history, and whether embryos have undergone PGT-A screening.
Choosing between single and double embryo transfer isn't simply about increasing the odds of pregnancy. It's about achieving the healthiest possible outcome for both mother and baby.
For most IVF patients, elective single embryo transfer offers an excellent chance of success while dramatically reducing the risks associated with twin pregnancies. Thanks to advances in embryo freezing and IVF technology, transferring embryos one at a time provides a similar overall chance of taking home a healthy baby from a complete treatment cycle.
If you're deciding how many embryos to transfer, the right choice depends on your age, embryo quality, fertility history, and whether your embryos have been genetically tested. A personalised consultation with your fertility specialist can help determine the safest and most effective approach for your treatment journey.
Book a consultation with MMC IVF today to discuss the embryo transfer strategy that's right for you.
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support.
MMCIVF and Zivanza Wellness are trademarks and tradenames owned by MUrgency Inc., USA.
Services listed on the MMCIVF.com website are available in each Country we provide services in through MMCIVF Affiliated Clinics licensed, regulated and supervised by the Competent Authorities in the respective Country and based on the applicable laws, rules and regulations in the respective Country / Jurisdiction.
MMCIVF operates Clinics in each Country as aforesaid above under the laws, rules and regulations of the respective Country. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Clinics and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents are expected to be fully compliant with the laws, rules and regulations in the respective Country and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents) are subject to. MMCIVF Country / MMCIVF Country Directors / MMCIVF Country Doctors / MMCIVF Country Nurses / MMCIVF Country Staff / MMCIVF Country Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the respective Country where treatment is sought and provided which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents.
Further, MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF Country policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. MMCIVF Country shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF Country for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF Country at info@mmcivf.ae immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF Country.
Further, MMCIVF in each Country operates independently and separately from other MMCIVF Clinics in Other Countries.
NOTE: Please read Country as respective Country – USA, Kenya, Georgia, Tanzania and United Arab Emirates as appropriate, relevant and applicable.